sorafenib has been researched along with Adjuvant Arthritis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Gong, YF; Huang, TY; Huang, XY; Wang, ZZ; Zhang, XM | 1 |
Gong, Y; Huang, T; Huang, X; Liu, B; Wang, J; Wang, Z; Yu, Q | 1 |
Gong, YF; Huang, TY; Huang, XY; Liu, F; Wang, ZZ; Zhang, XM | 1 |
3 other study(ies) available for sorafenib and Adjuvant Arthritis
Article | Year |
---|---|
Effects of sorafenib on fibroblast-like synoviocyte apoptosis in rats with adjuvant arthritis.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Arthritis, Experimental; Caspase 3; Cells, Cultured; fas Receptor; Freund's Adjuvant; Male; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Sorafenib; Synoviocytes | 2020 |
Sorafenib suppresses proliferation rate of fibroblast-like synoviocytes through the arrest of cell cycle in experimental adjuvant arthritis.
Topics: Animals; Antirheumatic Agents; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Culture Techniques; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Down-Regulation; Fibroblasts; G1 Phase Cell Cycle Checkpoints; Hyperplasia; Mice; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Sorafenib; Synovial Membrane; Synoviocytes | 2021 |
Antiarthritic Effects of Sorafenib in Rats with Adjuvant-Induced Arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cytokines; Freund's Adjuvant; Male; Rats; Rats, Sprague-Dawley; Sorafenib; Treatment Outcome | 2018 |